Speakers & Moderators

This page was updated in December 2025, following the conference. It now features the slides of speakers who presented with slides during VISION EUROPE 2030, available for download directly from the page.

To make it clear which speakers have slides available, the background of their profile pictures has been changed from white to the light blue of the Vision Europe logo. Clicking on the profile of a speaker with a blue background will redirect you to that speaker’s slides.

Speaker 1

Ruggero De Maria

Alleanza Contro il Cancro; Professor of Pathology, Università Cattolica del Sacro Cuore, Rome

Speaker 1

Denis Horgan

Executive Director, European Alliance for Personalised Medicine (EAPM)

Slides available
Speaker 1

Peder Myhre

Professor, Department of Cardiology, University of Oslo

Speaker 1

Peter Schirmacher

Director of Pathology, University Hospital Heidelberg; CMO, European Association for Cancer Research (EACR)

Speaker 1

Christine Chomienne

Vice-Chair, Horizon Europe Cancer Mission Board

Speaker 1

Maari Parkkinen

Project Coordinator, FinHITS and Development Manager, Findata

Speaker 1

Goradana Raicevix Toungouze

Scientific Coordinator at Sciensano

Speaker 1

Zisis Kozlakidis

Head of the Laboratory Services and Biobank Group (LSB) at IARC

Slides available
Speaker 1

Anabela Isidro

Coordinator of ECHoS project & Member of the Board AICIB

Speaker 1

Marc Van den Bulcke

Head of Service, Belgian Cancer Centre, Sciensano

Speaker 1

Manuel Ottaviano

Associate professor, Researcher, Project Manager, Universidad Politecnica de Madrid

Speaker 1

Hans-Peter Brunner-La Rocca

University of Maastricht, public co-lead

Slides available
Speaker 1

Jana Seuthe

German Foundation for the Chronically Ill

Speaker 1

Robin van Stokkum

Digital Health Technologies, TNO, Dutch Organisation for Applied Research and Innovation

Speaker 1

Frédéric Destrebecq

Executive Director at the European Brain Council

Speaker 1

Rossana Alessandrello

Value Based Procurement Director, AQUAS

Speaker 1

Peter Kapitein

Patient Advocate at Inspire2Live

Speaker 1

Marcis Leja

University of Latvia, Coordinator of EUCanScreen

Speaker 1

Joanne M. Hackett

Vice President Health System Services, IQVIA

Speaker 1

George Kapetanakis

President, Hellenic Cancer Federation – ELLOK

Speaker 1

Rui Amaral Mendes

Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto

Speaker 1

Pascal Garel

Chief Executive, European Hospital and Healthcare Federation (HOPE)

Speaker 1

Delia Nicoară

Public Health and Management Specialist, Oncology Institute “Prof. Dr. Ion Chiricuță,” Cluj-Napoca, Romania

Speaker 1

Jose M. Martin-Moreno

Professor of Medicine and Public Health, University of Valencia & Chair of Innovative Health Management, Spanish Economy and Health Foundation

Speaker 1

Tilly Metz

Member of the European Parliament (Luxembourg), Greens/EFA group and the national party Déi Gréng – Les Verts

Speaker 1

Carmen Laplaza Santos

Head of Unit, Health Innovations & Ecosystems, DG RTD, European Commission

Speaker 1

Thomas di Maio

Head of Diagnostics for Europe and Canada, AstraZeneca

Speaker 1

Elil Renganathan

Professor, Public Health and Policy, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia

Speaker 1

Antoni Montserrat Moliner

Vice président - ALAN Vice President, National Committee of the Rare Diseases Plan of Luxembourg

Speaker 1

Catherine Alix-Panabières

Professor of Oncology (PU-PH), Faculty of Medicine of Montpellier, France

Slides available
Speaker 1

Hesham Elghazaly

President, Egyptian Cancer Society & Director, MASRI Research Center

Slides available
Speaker 1

Jesús García-Foncillas

President, Fundacion ECO & Director of the Oncology Department, Fundacion Jimenez Díaz University Hospital

Speaker 1

Kjetil Tasken

Head of Institute, Institute for Cancer Research, Oslo University Hospital, Norway

Speaker 1

Irene Braña

Head and Neck Cancer Group at VHIO, is also the Global Principal Investigator of the BoB trial

Speaker 1

Brian Ward

Director of Advocacy and European Affairs, European Respiratory Society

Speaker 1

Christophe Le Tourneau

Head, Early Phase Clinical Trials Program & Head & Neck Oncology, Head, Department of Drug Development & Innovation (D3i), Institut Curie, Paris, France

Speaker 1

Alejandro Piris

Head of the Scientific Coordination/ Management Area at the Vall d'Hebron Institute of Oncology (VHIO), Barcelona

Speaker 1

Klaus Pantel

Director, Institute of Tumor Biology, Centre for Experimental Medicine, University Medical

Speaker 1

Iris Faull

Global CMO, SYNLAB International

Speaker 1

Josep Figueras

Director Emeritus, European Observatory on Health Systems and Policies

Speaker 1

Adamu Addissie

Co CEO, Network for Oncology Research in Sub-Saharan Africa

Slides available
Speaker 1

Jin Yamamura

General Manager, Care Area & Digital Monetization, International General Manager, Care Area & Digital Monetization, International GE HealthCare

Speaker 1

Anton Ussi

Operations & Finance Director for EATRIS C&S

Speaker 1

Christine Leopold

Assistant Professor, Utrecht University, Division of Pharmacoepidemiology & Clinical Pharmacology, Netherlands

Speaker 1

Donna Fitzsimons

Head of Nursing & Midwifery, Queen’s University Belfast and a former ESC Board Member

Speaker 1

Birgit Beger

Chief Executive Officer, European Heart Network

Slides available
Speaker 1

Philippe Amouyel

French Foundation of Scientific co-operation in Alzheimer’s Disease, France

Slides available
Speaker 1

Philippe Vernier

Co‑Chief Executive Officer (Co‑CEO), EBRAINS

Speaker 1

Roberto Grasso

Department of Oncology and Hemato-Oncology, University of Milan

Speaker 1

Vytenis Povilas Andriukaitis

MEP, European Parliament

Speaker 1

Michael Makanga

CEO, EDCTP

Speaker 1

Stephen McMahon

CEO, Irish Patient Association

Speaker 1

Ingrid Kruecken

Vice President, Europa Donna Luxembourg

Speaker 1

Ishtar Espejo Castellá

Executive Director, Fundación Aladina

Speaker 1

Szymon Bielecki

Team Leader - EU policies, Unit H.3., eHealth, Well-Being and Ageing, DG CONNEC

Slides available
Speaker 1

Neeme Tõnisson

Professor, Estonian Biobank, Institute of Genomics, University of Tartu

Speaker 1

Lee-Anne Zinetti

Executive Director, Global Oncology Portfolio Precision Medicine Strategy, Novartis

Speaker 1

Benjamin Gannon

Vice President Europe & Americas at Guardant Health

Speaker 1

Daniel Morales

Senior Clinical Epidemiologist, Data Analytics Taskforce, European Medicine Agency

Slides available
Speaker 1

Marcus Guardian

General Manager of the International Horizon Scanning Initiative (IHSI)

Speaker 1

Jens K. Habermann

Director General, BBMRI

Speaker 1

Live Fagereng

Project Manager, PRIME-ROSE

Speaker 1

Maria Eugenia (Xenia) Beltran

Senior Project Manager, Bridg-OU (BRECISE)

Speaker 1

Phil Hogan

Former EU Commissioner for Trade

Speaker 1

Raili Sillart

Estonian Ministry of Social Affairs

Slides available
Speaker 1

Sahar van Waalwijk van Doorn-Khosrovani

Senior Advisor, CZ, The Netherlands

Speaker 1

Jacqueline Bowman

Founder, Third-i bv, IMI- SOPHIA Work Package Co-Lead (Shared Value Analysis)

Speaker 1

Daniela Chieffo

Department of Health Science and Public Health Fondazione Policlinico Gemelli, IRCCS Catholic University of Sacred Heart, Rome

Slides available
Speaker 1

Adda Bounedjar

Head of Oncology, Central Hospital of Algiers & President, Algerian Society for Training and Research in Oncology (SAFRO)

Slides available
Speaker 1

Katja Herzog

Scientific Project Coordinator, Fraunhofer ITMP

Speaker 1

Vittoria Carraro

Policy Officer, ‘Cancer, Health in all Policies’, DG Santé

Slides available
Speaker 1

Marilys Corbex

Senior technical officer, WHO Europe